PDCD10

PDCD10

PDCD10, also known as Programmed Cell Death 10, is a protein encoded by the PDCD10 gene in humans. This protein is involved in various cellular processes, including cell proliferation, apoptosis, and angiogenesis. Mutations in the PDCD10 gene are associated with cerebral cavernous malformations (CCM), a condition characterized by vascular lesions in the brain that can lead to seizures, headaches, and hemorrhagic stroke.

Structure

The PDCD10 protein is composed of 212 amino acids and has a molecular weight of approximately 24 kDa. It contains a conserved domain known as the CCM3 domain, which is crucial for its interaction with other proteins involved in the CCM signaling pathway. The protein is predominantly localized in the cytoplasm but can also be found in the nucleus under certain conditions.

Function

PDCD10 plays a critical role in maintaining vascular integrity and endothelial cell function. It interacts with several other proteins, including KRIT1, CCM2, and STRIPAK complex components, to regulate signaling pathways that control cell shape, migration, and survival. PDCD10 is also involved in the regulation of the mitogen-activated protein kinase (MAPK) pathway, which is essential for cell growth and differentiation.

Role in Apoptosis

PDCD10 is implicated in the regulation of apoptosis, or programmed cell death. It can modulate apoptotic pathways by interacting with proteins such as caspases and Bcl-2 family proteins. The exact mechanism by which PDCD10 influences apoptosis is still under investigation, but it is believed to involve the modulation of mitochondrial pathways and the regulation of reactive oxygen species (ROS) production.

Role in Angiogenesis

PDCD10 is essential for angiogenesis, the process of new blood vessel formation. It regulates endothelial cell proliferation and migration, which are critical steps in angiogenesis. PDCD10 deficiency can lead to impaired angiogenic responses, contributing to the development of vascular malformations.

Clinical Significance

Mutations in the PDCD10 gene are one of the genetic causes of cerebral cavernous malformations (CCM). These mutations can lead to the loss of function of the PDCD10 protein, resulting in abnormal blood vessel formation and increased risk of hemorrhage. Genetic testing for PDCD10 mutations is available for individuals with a family history of CCM or those presenting with symptoms suggestive of the condition.

Research Directions

Current research on PDCD10 focuses on understanding its precise molecular functions and interactions, as well as its role in disease pathogenesis. Studies are also exploring potential therapeutic strategies to target PDCD10-related pathways for the treatment of CCM and other vascular disorders.

Also see

• Cerebral cavernous malformation
• KRIT1
• CCM2
• Apoptosis
• Angiogenesis

Resources

Latest articles - PDCD10

• Most recent articles
• Ongoing trials

Source: Data courtesy of the U.S. National Library of Medicine. Since the data might have changed, please query MeSH on PDCD10 for any updates.

‎